Indian Regulator Flags Abhayrab Rabies Vaccine Batch as Substandard; Manufacturer Denies Production
India's drug regulator flagged a batch of Abhayrab rabies vaccine (batch KE25012) as substandard and misbranded after failing a potency test by the Central Drugs Laboratory in Kasauli. Indian Immunologicals Limited (IIL) clarified that the questioned vials were not manufactured by its Human Biologicals Institute division, citing 17 differences from genuine samples. IIL has submitted records to authorities and requested an investigation to trace the source of the vials, confirming cooperation with regulators.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (49/100). Lens Score 60/100.
Outlets measured: economictimes, businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (45–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 5 Sept, 02:24 am. Other outlets followed.